Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
As of June 10, 2026, new enrollees are on the Shed Promise 120-Day Guarantee: lose at least 5% of baseline body weight or reach your enrolled goal weight within 120 days of your first medication shipment
Wegovy is FDA-approved for chronic weight management, while Ozempic is approved for type 2 diabetes and cardiovascular risk reduction
It increases insulin release when blood sugar is high and lowers the amount of sugar that the liver makes
Tools like the GLP-1 plotter can help visualize your progress from the very first week
Beyond this, ongoing research has shown that Semaglutide may offer additional benefits such as improved cardiovascular health, potential kidney protection, and even cognitive support
In that 2024 study, patients with type 2 diabetes prescribed semaglutide had a 36-month NAION incidence of 8.9%, compared to 1.8% in patients taking non-GLP-1 diabetes medications
US$ 20.32
US$ 28.91
US$ 21.25
US$ 27.19
US$ 20.39
US$ 26.85
US$ 20.10
